Pepper Bio’s ‘Google Maps for Drug Discovery’ Finds Way to Potential New Liver Cancer Drug
Pepper Bio’s drug-hunting efforts have turned up its first clinical-stage drug candidate, but not by discovering a novel molecule in ...
Sunday, February 23, 2025
Tag: drug
EMA and delays in drug launch
For patients with serious illnesses, timeline access to efficacious medications is paramount. The European Medicines Agency (EMA) was created in ...
Blockbuster BeiGene Cancer Drug Adds Another FDA Approval
A BeiGene drug already used to treat several types of blood cancer now has an additional FDA approval as a ...
Citi starts ArriVent stock with buy rating citing promising lung cancer drug
© Reuters. Tuesday, Citi initiated coverage on ArriVent BioPharma (NASDAQ:AVBP) with a Buy rating and a price target of $30.00. ...
Elation Health’s New Integration Brings Drug Pricing Transparency to the Point of Care for PCPs
For U.S. consumers, the pharmacy can sometimes be a bit of a scary place. Many Americans have been hit with ...
Pfizer agrees to pay $93 million to settle Lipitor drug antitrust lawsuit
Pfizer in a statement called the allegations "factually and legally without merit Pfizer has agreed to pay $93 million to ...
Eli Lilly Fatty Liver Drug Posts Promising Early Data, But Field Is Still Competitive
Eli Lilly metabolic disorder medication tirzepatide, already approved in type 2 diabetes and weight management, now has early clinical data ...
North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030
North Carolina is cutting off coverage of anti-obesity medications for state employees, citing soaring costs and a lack of agreement ...
A primer on brand-name prescription drug reimbursement in the US
That is the title of a recent paper by Hernandez and Hung (2024). The article ...
Manufacturing Issues Block Astellas From a First-in-Class Cancer Drug Approval
Astellas Pharma’s path to winning the first drug approval for a particular promising gastrointestinal cancer target has hit a detour. ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.